Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2202
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure ; volume:15 ; number:1 ; day:21 ; month:7 ; year:2014 ; pages:1-11 ; date:12.2014
BMC neuroscience ; 15, Heft 1 (21.7.2014), 1-11, 12.2014
- Urheber
-
Rockenstein, Edward
- Beteiligte Personen und Organisationen
-
Ubhi, Kiren
Trejo, Margarita
Mante, Michael
Patrick, Christina
Adame, Anthony
Novak, Philipp
Jech, Marion
Doppler, Edith
Moessler, Herbert
Masliah, Eliezer
SpringerLink (Online service)
- DOI
-
10.1186/1471-2202-15-90
- URN
-
urn:nbn:de:1111-2016032122335
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rockenstein, Edward
- Ubhi, Kiren
- Trejo, Margarita
- Mante, Michael
- Patrick, Christina
- Adame, Anthony
- Novak, Philipp
- Jech, Marion
- Doppler, Edith
- Moessler, Herbert
- Masliah, Eliezer
- SpringerLink (Online service)
Ähnliche Objekte (12)
Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys
Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
Caenorhabditis elegans model of tauopathy
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
Modeling pathological consequences of astrocytic tauopathy
Irisin inhibits microglial senescence via TFAM-mediated mitochondrial metabolism in a mouse model of tauopathy
Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
A seeding based cellular assay of tauopathy
Quantitative Studies of Tau Protein and Tauopathy
Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys
Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
Caenorhabditis elegans model of tauopathy
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
Modeling pathological consequences of astrocytic tauopathy
Irisin inhibits microglial senescence via TFAM-mediated mitochondrial metabolism in a mouse model of tauopathy
Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
A seeding based cellular assay of tauopathy
Quantitative Studies of Tau Protein and Tauopathy
Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys
Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy
Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
Caenorhabditis elegans model of tauopathy
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
Modeling pathological consequences of astrocytic tauopathy
Irisin inhibits microglial senescence via TFAM-mediated mitochondrial metabolism in a mouse model of tauopathy
Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
A seeding based cellular assay of tauopathy